… In this Review, we aim to assist clinicians in navigating the 2011 ACCF/AHA 14 and 2014
ESC 15 guidelines for HCM by surveying the main points of divergence, key updates, …

… Cardiomyopathy” (1). The current version will replace the 2011 guideline and addresses …
and management of adults and children with hypertrophic cardiomyopathy (HCM). Diagnostic …

… Many recommendations from the earlier hypertrophic cardiomyopathy guidelines have
been updated with new evidence or a better understanding of earlier evidence. This summary …

… Both ACCF/AHA guidelines (Class IIa) and ESC guidelines include unexplained syncope
in ICD decision making. LVOT obstruction has been linked to SCD (Online Ref. 44) and is a …

… Sudden cardiac death (SCD) risk stratification is the most important preventive action in
patients with hypertrophic cardiomyopathy (HCM). The identification of the ischemia biomarker …

… Hypertrophic cardiomyopathy (HCM) is an inherited cardiac condition associated with … .
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task …

… children with hypertrophic cardiomyopathy (HCM). The European Society of Cardiology (ESC) …
This study sought to perform the first validation of the 2014 ESC guidelines in a cohort of …

… Society of Cardiology (ESC) guidelines, was retrospectively … 4%/5 years, regarded by ESC
as insufficient to recommend ICDs, and … In conclusion, primary risk stratification using the ESC …

… The ESC published a guideline on the management of cardiomyopathies in 2023. Table 2
compares the recommendations assessing the risk of SCD in children and adolescents, the …

… 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy:
the task force for the diagnosis and management of hypertrophic cardiomyopathy of the …